CRP and acute lymphoblastic leukemia: The m-EASIX (LDH*CRP/Platelets) was applied to adults with B-ALL and DLBCL with higher scores significantly associated with development of severe CRS and ICANS at specific timepoints, as well as reduced odds of overall response [106].